Hepatic failure associated with imipramine therapy

Y. Ilan; D. Samuel; M. Reynes; Ran Tur-Kaspa

doi:10.1055/s-2007-979549

Hepatic failure associated with imipramine therapy

Y. Ilan, D. Samuel, M. Reynes, Ran Tur-Kaspa

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities. These are usually minor and transient liver enzyme elevations which return to normal levels upon discontinuation of the drug. We describe a 48-year-old male who developed subfulminant hepatic failure after imipramine usage, with complete recovery within three months after discontinuation of the drug.

Original language	English
Pages (from-to)	79-80
Number of pages	2
Journal	Pharmacopsychiatry
Volume	29
Issue number	2
DOIs	https://doi.org/10.1055/s-2007-979549
State	Published - Mar 1996
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1055/s-2007-979549

Cite this

@article{2ba6efe5ab6a49189bd456f1af928a82,

title = "Hepatic failure associated with imipramine therapy",

abstract = "Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities. These are usually minor and transient liver enzyme elevations which return to normal levels upon discontinuation of the drug. We describe a 48-year-old male who developed subfulminant hepatic failure after imipramine usage, with complete recovery within three months after discontinuation of the drug.",

author = "Y. Ilan and D. Samuel and M. Reynes and Ran Tur-Kaspa",

year = "1996",

month = mar,

doi = "10.1055/s-2007-979549",

language = "אנגלית",

volume = "29",

pages = "79--80",

journal = "Pharmacopsychiatry",

issn = "0176-3679",

publisher = "Georg Thieme Verlag",

number = "2",

}

TY - JOUR

T1 - Hepatic failure associated with imipramine therapy

AU - Ilan, Y.

AU - Samuel, D.

AU - Reynes, M.

AU - Tur-Kaspa, Ran

PY - 1996/3

Y1 - 1996/3

N2 - Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities. These are usually minor and transient liver enzyme elevations which return to normal levels upon discontinuation of the drug. We describe a 48-year-old male who developed subfulminant hepatic failure after imipramine usage, with complete recovery within three months after discontinuation of the drug.

AB - Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities. These are usually minor and transient liver enzyme elevations which return to normal levels upon discontinuation of the drug. We describe a 48-year-old male who developed subfulminant hepatic failure after imipramine usage, with complete recovery within three months after discontinuation of the drug.

UR - https://www.scopus.com/pages/publications/0029960317

U2 - 10.1055/s-2007-979549

DO - 10.1055/s-2007-979549

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 8741026

AN - SCOPUS:0029960317

SN - 0176-3679

VL - 29

SP - 79

EP - 80

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

IS - 2

ER -

Hepatic failure associated with imipramine therapy

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this